Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Total 13F shares
-
13,086,618
-
Share change
-
-106,572
-
Total reported value
-
$37,292,000
-
Price per share
-
$2.85
-
Number of holders
-
35
-
Value change
-
-$263,164
-
Number of buys
-
9
-
Number of sells
-
13
Institutional Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q1 2019
As of 31 Mar 2019 Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) had 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,086,618 shares of stock of the company.
Largest 10 holders included STONEHILL CAPITAL MANAGEMENT LLC, Paradice Investment Management LLC, JANUS HENDERSON GROUP PLC, HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC, FIRST WILSHIRE SECURITIES MANAGEMENT INC, 22NW, LP, Russell Investments Group, Ltd., HEARTLAND ADVISORS INC, Lapides Asset Management, LLC, and RENAISSANCE TECHNOLOGIES LLC.
This table shows 35 institutional shareholders of the security as of 31 Mar 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.